| Role |
Name |
Disclosure |
Details |
| Author | Peter E Darwin, MD, Associate Professor, Director of GI Endoscopy, Department of Medicine, Division of Gastroenterology, University of Maryland School of Medicine | Nothing to disclose | Details | | Coauthor | Andrew Scott Kennedy, MD, Co-Medical Director, Wake Radiology Oncology | Nothing to disclose | Details | | Coauthor | Jennifer Lynn Bonheur, MD, Attending Physician, Division of Gastroenterology, Lenox Hill Hospital | Nothing to disclose | Details | | Coauthor | David Van Echo, MD, Head, New Drug Development Program (Oncology), Professor, Departments of Medicine and Pharmacy, University of Maryland School of Medicine | Nothing to disclose | Details | | Medical Editor | Michael Perry, MD, MS, MACP, Nellie B Smith Chair of Oncology, Professor, Department of Internal Medicine, Division of Hematology and Oncology, University of Missouri at Columbia/Ellis Fischel Cancer Center | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Benjamin Movsas, MD, Vice-Chairman, Department of Radiation Oncology, Fox Chase Cancer Center | Nothing to disclose | Details | | CME Editor | Rajalaxmi McKenna, MD, FACP, Consulting Staff, Department of Medicine, Southwest Medical Consultants, SC, Good Samaritan Hospital, Advocate Health Systems | Nothing to disclose | Details | | Chief Editor | Jules E Harris, MD, Visiting Professor of Medicine, Division of Hematology/Medical Oncology, Department of Internal Medicine, University of Arizona College of Medicine at Tucson; Consulting Staff, Arizona Cancer Center | GlobeImmune Amplimed | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Andrew Scott Kennedy, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| David Van Echo, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Benjamin Movsas, Managing Editor |
The contributor discloses no conflict of interest. |
|